Doubly prenylated tryptamines: cytotoxicity, antimicrobial activity and cyclisation to the marine natural product flustramine A

被引:23
作者
Adla, Santosh Kumar [1 ]
Sasse, Florenz [2 ]
Kelter, Gerhard [3 ]
Fiebig, Heinz-Herbert [3 ]
Lindel, Thomas [1 ]
机构
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, D-38106 Braunschweig, Germany
[2] Helmholtz Ctr Infect Res, Dept Biol Chem, D-38124 Braunschweig, Germany
[3] Oncotest Inst Expt Oncol GmbH, D-79108 Freiburg, Germany
关键词
SECONDARY METABOLITES; BIOLOGICAL EVALUATION; INDOLE ALKALOIDS; FOLIACEA; (-)-DEBROMOFLUSTRAMINE-B; (+/-)-FLUSTRAMINE-A; ALPHA-4-BETA-2; REARRANGEMENT; STRATEGY;
D O I
10.1039/c3ob40896e
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The marine natural product flustramine A was synthesised via oxidative cyclisation of N-b-methylated 1-prenyl-2-tert-prenyl-6-bromotryptamine and subsequent reduction of the resulting amidinium salt. Only the tert-prenyl group migrated, whereas the 1-prenyl group remained in place. Interestingly, the 2-tert-prenylated precursor revealed to be the biologically most active of our entire series of 21 compounds. Required for cytotoxicity and antimicrobial activity was the presence of a non-cyclised tryptamine side chain carrying a free secondary amine, whereas the presence of a 6-bromo substituent did not enhance cytotoxicity. In a panel of 42 human tumor cell lines, most sensitive were the lung and mammary cancer cell lines LXFA629L (IC50 1.9 mu M) and MAXF401NL (IC50 2.4 mu M), respectively. In a serial dilution assay, satisfying IC50 values of 5.9 mu M against Micrococcus luteus and 7.7 mu M each against Mycobacterium phlei were determined for N-b-methyl-1-prenyl-2-tert-prenyl-6-bromotryptamine.
引用
收藏
页码:6119 / 6130
页数:12
相关论文
共 32 条
[1]   Study on the NBS-Induced Rearrangement of 2-tert-Prenyltryptamines [J].
Adla, Santosh Kumar ;
Golz, Gregor ;
Jones, Peter G. ;
Lindel, Thomas .
SYNTHESIS-STUTTGART, 2010, (13) :2161-2170
[2]   Flustramine inspired synthesis and biological evaluation of pyrroloindoline triazole amides as novel inhibitors of bacterial biofilms [J].
Bunders, Cynthia ;
Cavanagh, John ;
Melander, Christian .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2011, 9 (15) :5476-5481
[3]   Intercepting Bacterial Indole Signaling with Flustramine Derivatives [J].
Bunders, Cynthia A. ;
Minvielle, Marine J. ;
Worthington, Roberta J. ;
Ortiz, Minoshka ;
Cavanagh, John ;
Melander, Christian .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (50) :20160-20163
[4]   A synthetic strategy using Witkop's pyrroloindole for (-)-debromoflustramine B, (+)-ent-debromoflustramine B and (+)-ent-debromoflustramide B [J].
Cardoso, A. Sofia P. ;
Marques, M. Manuel B. ;
Srinivasan, Natarajan ;
Prabhakar, Sundaresan ;
Lobo, Ana M. .
TETRAHEDRON, 2007, 63 (41) :10211-10225
[5]   A new synthesis of (-)-debromoflustramine B, (+)-ent-debromoflustramine B and (+)-debromoflustramide B [J].
Cardoso, AS ;
Srinivasan, N ;
Lobo, AM ;
Prabhakar, S .
TETRAHEDRON LETTERS, 2001, 42 (38) :6663-6666
[6]   BROMO-SUBSTITUTED PHYSOSTIGMINE ALKALOIDS FROM A MARINE BRYOZOA FLUSTRA-FOLIACEA [J].
CARLE, JS ;
CHRISTOPHERSEN, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1979, 101 (14) :4012-4013
[7]   MARINE ALKALOIDS .2. BROMO ALKALOIDS FROM THE MARINE BRYOZOAN FLUSTRA-FOLIACEA - ISOLATION AND STRUCTURE ELUCIDATION [J].
CARLE, JS ;
CHRISTOPHERSEN, C .
JOURNAL OF ORGANIC CHEMISTRY, 1980, 45 (09) :1586-1589
[8]   DEVELOPMENT OF A PROPIDIUM IODIDE FLUORESCENCE ASSAY FOR PROLIFERATION AND CYTOTOXICITY ASSAYS [J].
DENGLER, WA ;
SCHULTE, J ;
BERGER, DP ;
MERTELSMANN, R ;
FIEBIG, HH .
ANTI-CANCER DRUGS, 1995, 6 (04) :522-532
[9]   Indol-2-one intermediates:: Mechanistic evidence and synthetic utility.: Total syntheses of (±)-flustramines A and C [J].
Fuchs, JR ;
Funk, RL .
ORGANIC LETTERS, 2005, 7 (04) :677-680
[10]   Deconstruction of the α4β2 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Desformylflustrabromine [J].
German, Nadezhda ;
Kim, Jin-Sung ;
Jain, Atul ;
Dukat, Malgorzata ;
Pandya, Anshul ;
Ma, Yilong ;
Weltzin, Maegan ;
Schulte, Marvin K. ;
Glennon, Richard A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) :7259-7267